Ginkgo Bioworks Holdings, Inc. DNA
$6.79
-6.22%
at last close
Analyst Consensus
- Consensus Rating
- Reduce (0 Buy · 1 Hold · 1 Sell)
- Average Price Target
- $7.00
- Implied Upside
- +3.1%
- Price Target Range
- $5.00 – $9.00
- Analysts (12 mo)
- 2
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-07 | TD CowenBrendan Smith |
Downgrades | Buy → Hold | $12 → $9 |
| 2026-03-12 | BTIGMark Massaro |
Maintains | Sell | $9 → $5 |
| 2026-01-08 | TD CowenBrendan Smith |
Maintains | Buy | $14 → $12 |
| 2025-08-25 | BTIGMark Massaro |
Maintains | Sell | $6 → $9 |
| 2024-09-20 | TD CowenBrendan Smith |
Maintains | Buy | $3 → $10 |
| 2024-08-23 | BTIGMark Massaro |
Maintains | Sell | $0 → $7 |
| 2024-07-09 | Goldman SachsMatthew Sykes |
Maintains | Sell | $32 → $12 |
| 2024-06-26 | BTIGMark Massaro |
Maintains | Sell | $20 → $8 |
| 2024-05-15 | BTIGMark Massaro |
Downgrades | Neutral → Sell | — |
| 2024-05-15 | Morgan StanleyTejas Savant |
Maintains | Equal-weight | $80 → $40 |
| 2024-05-10 | William BlairMatt Larew |
Downgrades | Market perform → Underperform | — |
| 2024-03-01 | TD CowenSteven Mah |
Maintains | Outperform | $280 → $120 |
| 2024-01-23 | Goldman SachsMatthew Sykes |
Maintains | Sell | $50 → $44 |
| 2024-01-22 | Goldman SachsMatthew Sykes |
Maintains | Sell | $50 → $44 |
| 2023-11-15 | Raymond JamesRahul Sarugaser |
Downgrades | Outperform → Market perform | $100 |
| 2023-11-14 | Raymond JamesRahul Sarugaser |
Downgrades | Outperform → Market perform | $100 |
| 2023-11-09 | BTIGMark Massaro |
Downgrades | Buy → Neutral | — |
| 2023-06-05 | Goldman SachsMatthew Sykes |
Maintains | Sell | $120 → $50 |
| 2023-06-02 | Goldman SachsMatthew Sykes |
Downgrades | Neutral → Sell | $120 → $50 |
| 2023-05-11 | William BlairMatt Larew |
Downgrades | Outperform → Market perform | — |
| 2022-11-29 | BerenbergGaurav Goparaju |
Initiates coverage on | Buy | $240 |
| 2022-10-04 | Morgan StanleyTejas Savant |
Initiates coverage on | Equal-weight | $200 |
| 2022-08-16 | BTIGMark Massaro |
Maintains | Buy | $200 → $240 |
| 2022-08-16 | Raymond JamesRahul Sarugaser |
Maintains | Outperform | $460 → $580 |
| 2022-06-16 | JefferiesLaurence Alexander |
Maintains | Buy | $460 → $174 |
| 2022-05-18 | B of A SecuritiesDerik De Bruin |
Downgrades | Neutral → Underperform | $240 → $120 |
| 2022-03-02 | Cowen & Co.Steven Mah |
Initiates coverage on | Outperform | $480 |
| 2022-02-23 | Goldman SachsMatthew Sykes |
Initiates coverage on | Neutral | $280 |
| 2022-02-01 | B of A SecuritiesDerik De Bruin |
Initiates coverage on | Neutral | $240 |
| 2022-01-28 | B of A SecuritiesDerik De Bruin |
Initiates coverage on | Buy | $320 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $6.79
- Market Cap
- $457.24 million
- 52-Week Range
- $5.37 – $17.58
- Average Volume
- 1.02 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.